Trial Outcomes & Findings for Effectiveness of Nanoone Woman Underwear Using in the Management of Dysmenorrhea (NCT NCT01449305)
NCT ID: NCT01449305
Last Updated: 2013-02-04
Results Overview
The severity of dysmenorrhea pain experienced by subjects will be evaluated on a VAS, ranging from zero (no pain) to ten (very severe pain).
COMPLETED
NA
44 participants
baseline, first menstrual cycle, second menstrual cycle and third menstrual cycle
2013-02-04
Participant Flow
Forty-four (44) subjects enrolled into the study. Forty-two (42) subjects completed the study from 2011-10-11 to 2012-06-23 at the PingTung Christian Hospital (60, Dallan Road, Pingtung, Taiwan).
This is an Open-label study design. The subject must be qualified for the study by fulfilling all of the inclusion and none of the exclusion criteria. Laboratory values which are out of reference range will not qualify unless the physician deems the deviation not clinically significant (NCS).
Participant milestones
| Measure |
Nanoone Woman Underwear
"Nanoone" negative ion of textiles, which is health material specifically designed for human body, in short distance and long time to produce negative ion, the human body really needed, it can neutralize free radical in the human body. The subjects were required to wear the Nanoone Woman Underwear during each menstrual cycle for a total of three consecutive menstrual cycles.
|
|---|---|
|
Overall Study
STARTED
|
44
|
|
Overall Study
COMPLETED
|
42
|
|
Overall Study
NOT COMPLETED
|
2
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Effectiveness of Nanoone Woman Underwear Using in the Management of Dysmenorrhea
Baseline characteristics by cohort
| Measure |
Nanoone Woman Underwear
n=44 Participants
"Nanoone" negative ion of textiles, which is health material specifically designed for human body, in short distance and long time to produce negative ion, the human body really needed, it can neutralize free radical in the human body. The subjects were required to wear the Nanoone Woman Underwear during each menstrual cycle for a total of three consecutive menstrual cycles.
|
|---|---|
|
Age, Categorical
<=18 years
|
3 Participants
n=5 Participants
|
|
Age, Categorical
Between 18 and 65 years
|
41 Participants
n=5 Participants
|
|
Age, Categorical
>=65 years
|
0 Participants
n=5 Participants
|
|
Age Continuous
|
22.4 years
STANDARD_DEVIATION 4.2 • n=5 Participants
|
|
Sex: Female, Male
Female
|
44 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
0 Participants
n=5 Participants
|
|
Region of Enrollment
Taiwan
|
44 participants
n=5 Participants
|
PRIMARY outcome
Timeframe: baseline, first menstrual cycle, second menstrual cycle and third menstrual cyclePopulation: Subjects were asked to use the VAS scoring system to record, on a provided sheet, their experienced menstrual pain level daily during menstrual bleeding for a total of three consecutive menstrual cycles in house. Primary objective was analyzed based on the Per-protocol (PP) population.
The severity of dysmenorrhea pain experienced by subjects will be evaluated on a VAS, ranging from zero (no pain) to ten (very severe pain).
Outcome measures
| Measure |
Nanoone Woman Underwear
n=42 Participants
"Nanoone" negative ion of textiles, which is health material specifically designed for human body, in short distance and long time to produce negative ion, the human body really needed, it can neutralize free radical in the human body. The subjects were required to wear the Nanoone Woman Underwear during each menstrual cycle for a total of three consecutive menstrual cycles.
|
|---|---|
|
The Mean Change in Maximum Pain Level at Each Menstrual Cycle From Baseline
First menstrual cycle
|
-0.810 scores
Standard Deviation 2.04
|
|
The Mean Change in Maximum Pain Level at Each Menstrual Cycle From Baseline
Second menstrual cycle
|
-1.29 scores
Standard Deviation 1.81
|
|
The Mean Change in Maximum Pain Level at Each Menstrual Cycle From Baseline
Third menstrual cycle
|
-1.74 scores
Standard Deviation 2.24
|
OTHER_PRE_SPECIFIED outcome
Timeframe: first menstrual cycle, second menstrual cycle and third menstrual cyclePopulation: It was analyzed based on the PP population.
Continue taking pharmacological pain relief if required for subjects was allowed during study period, and it had been recorded.
Outcome measures
| Measure |
Nanoone Woman Underwear
n=42 Participants
"Nanoone" negative ion of textiles, which is health material specifically designed for human body, in short distance and long time to produce negative ion, the human body really needed, it can neutralize free radical in the human body. The subjects were required to wear the Nanoone Woman Underwear during each menstrual cycle for a total of three consecutive menstrual cycles.
|
|---|---|
|
Medicine Administration for Pain Relief During Study Period
First menstrual cycle
|
21.4 percentage of participants
|
|
Medicine Administration for Pain Relief During Study Period
Second menstrual cycle
|
9.52 percentage of participants
|
|
Medicine Administration for Pain Relief During Study Period
Third menstrual cycle
|
7.14 percentage of participants
|
Adverse Events
Nanoone Woman Underwear
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Mirror Hsieh
isRed Pharma & Biotech Research Corporation
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place